Company research / PTGX
Protagonist Therapeutics, Inc (PTGX)
- Sector Manufacturing
- Incorporated DE
- Fiscal year ends Dec 31
For the year ended 2025-12-31, Protagonist Therapeutics, Inc reported revenue of $46.02M. Revenue fell 89.4% from the prior annual period.
Key ratios (year ended 2025-12-31)
-343.6%
Operating margin
-282.8%
Net margin
-21.2%
Return on year-end equity
-89.4%
Revenue growth (YoY)
Beyond the statements
Follow the company.
Explore new filings, reported insider transactions and company relationships.